These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1437 related items for PubMed ID: 11787527

  • 1. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 2. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M.
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [Abstract] [Full Text] [Related]

  • 3. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2003 Jul 15; 76(1):216-24. PubMed ID: 12865813
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M.
    Clin Transplant; 1996 Aug 15; 10(4):357-63. PubMed ID: 8884109
    [Abstract] [Full Text] [Related]

  • 5. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 6. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H, Chilton PM, Huang Y, Schanie CL, Yan J, Ildstad ST.
    Transplantation; 2007 Apr 15; 83(7):954-63. PubMed ID: 17460568
    [Abstract] [Full Text] [Related]

  • 7. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance.
    Wekerle T, Nikolic B, Pearson DA, Swenson KG, Sykes M.
    Transpl Int; 2002 May 15; 15(5):248-53. PubMed ID: 12012046
    [Abstract] [Full Text] [Related]

  • 8. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S.
    Exp Hematol; 2004 Dec 15; 32(12):1246-54. PubMed ID: 15588949
    [Abstract] [Full Text] [Related]

  • 9. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y, Sachs DH, Khan A, Sykes M.
    Transplantation; 1996 Feb 15; 61(3):469-77. PubMed ID: 8610363
    [Abstract] [Full Text] [Related]

  • 10. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Kwon CH, Joh JW, Kim SJ.
    J Surg Res; 2006 Jan 15; 130(1):102-9. PubMed ID: 16183077
    [Abstract] [Full Text] [Related]

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 12. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H, LeGuern C, Sachs DH, Sykes M.
    Bone Marrow Transplant; 1996 Aug 15; 18(2):285-92. PubMed ID: 8864436
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T, Sozen H, Luo B, Heuss N, Kalscheuer H, Lan P, Sutherland DE, Hering BJ, Guo Z.
    Bone Marrow Transplant; 2002 Jun 15; 29(12):949-56. PubMed ID: 12098061
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
    Sharabi Y, Abraham VS, Sykes M, Sachs DH.
    Bone Marrow Transplant; 1992 Mar 15; 9(3):191-7. PubMed ID: 1387333
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 19. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.
    Nikolic B, Khan A, Sykes M.
    Biol Blood Marrow Transplant; 2001 Nov 10; 7(3):144-53. PubMed ID: 11302548
    [Abstract] [Full Text] [Related]

  • 20. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
    Mapara MY, Kim YM, Marx J, Sykes M.
    Transplantation; 2003 Jul 27; 76(2):297-305. PubMed ID: 12883182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.